Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
USA v. Babich et al
Case Number:
1:16-cr-10343
Court:
Nature of Suit:
Judge:
Firms
- Brown Rudnick
- Clark Hill
- Donnelly Conroy
- Fick & Marx
- Fitch Law Partners
- Hogan Lovells
- King & Spalding
- Kobre & Kim
- Miner Siddall
- Mitchell Stein Carey
- Morgan Lewis
- Nixon Peabody
- Ropes & Gray
- Weil Gotshal
- White & Case
- Wilkinson Stekloff
Companies
Sectors & Industries:
-
August 29, 2017
Atty May Need DQ In Insys Bribery Case, Feds Say
Prosecutors on Tuesday asked a Massachusetts federal judge to determine whether a defense attorney for one of the former Insys Therapeutics Inc. executives and managers accused of a nationwide opioid bribery scheme should be disqualified from the case, citing his prior representation of two government witnesses.
-
August 11, 2017
Patients Can Be Considered Victims In Insys Bribery Case
A Massachusetts federal judge allowed the federal government to use various alternative procedures to notify potential victims of Insys Therapeutics' alleged opioid racketeering and bribery scheme, finding that patients whose doctors took bribes can be considered victims.
-
July 27, 2017
Ex-Insys Execs, Prosecutors Spar Over Patient 'Victims'
Federal prosecutors asked a judge in Massachusetts on Thursday to let them pull out all the stops and get "creative" in finding ways to notify some 2,000 patients in the Insys opioid bribery case, prompting arguments from the pharmaceutical company's former executives that the patients aren't technically victims at all.
-
June 19, 2017
Ex-Insys Exec Cops To Opioid Fraud Scheme
A former manager at Insys Therapeutics on Monday admitted that she helped lead the drugmaker's nationwide scheme to defraud insurance companies by making them pay for expensive painkillers.
-
June 06, 2017
Ex-Insys Manager Will Plead Guilty To Insurance Fraud
A manager at Insys Therapeutics has agreed to plead guilty in a scheme to trick insurers into paying for the opioid spray Subsys, federal prosecutors told attorneys for six other defendants Monday in Massachusetts federal court.
-
January 05, 2017
Ex-Insys Execs Plead Not Guilty To Pain Pill Kickback Con
Four former executives of Insys Therapeutics pled not guilty Thursday of a scheme to pay doctors kickbacks for prescribing opioid painkillers at their first appearance in Boston federal court.
-
December 08, 2016
Ex-Insys Executives Charged In Painkiller Kickback Scheme
Six former executives of pharmaceutical company Insys Therapeutics Inc. were arrested and charged Thursday in Massachusetts federal court for allegedly conspiring to bribe doctors to prescribe the company's highly potent fentanyl-based pain medication, in the latest hit to the troubled drug company.